Leslie K. Chambers

2.5k total citations
10 papers, 1.2k citations indexed

About

Leslie K. Chambers is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Leslie K. Chambers has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Physiology. Recurrent topics in Leslie K. Chambers's work include Receptor Mechanisms and Signaling (5 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Leslie K. Chambers is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Leslie K. Chambers collaborates with scholars based in United States. Leslie K. Chambers's co-authors include Hans Rollema, Raymond S Hurst, Kathryn Williams, Lorraine A. Lebel, Frank S. Menniti, Robert S. Mansbach, Stephen M. Stahl, Jotham W. Coe, Yi Lu and Eric Schaeffer and has published in prestigious journals such as Journal of Medicinal Chemistry, Trends in Pharmacological Sciences and Biochemical Pharmacology.

In The Last Decade

Leslie K. Chambers

10 papers receiving 1.2k citations

Peers

Leslie K. Chambers
F. David Tingley United States
Salvador Sierra United States
Steven B. Sands United States
Martin R. Gluck United States
Srihari R. Tella United States
Richard E. Chipkin United States
Cornelia Dorner‐Ciossek Germany
Elin Löf Sweden
L. Oreland Sweden
Gunnar Flik Netherlands
F. David Tingley United States
Leslie K. Chambers
Citations per year, relative to Leslie K. Chambers Leslie K. Chambers (= 1×) peers F. David Tingley

Countries citing papers authored by Leslie K. Chambers

Since Specialization
Citations

This map shows the geographic impact of Leslie K. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie K. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie K. Chambers more than expected).

Fields of papers citing papers by Leslie K. Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie K. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie K. Chambers. The network helps show where Leslie K. Chambers may publish in the future.

Co-authorship network of co-authors of Leslie K. Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie K. Chambers. A scholar is included among the top collaborators of Leslie K. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie K. Chambers. Leslie K. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Coe, Jotham W., Paige R. Brooks, Michael Wirtz, et al.. (2009). Low efficacy partial agonists of the α4β2 nicotinic acetylcholine receptor (nAChR). Does functional efficacy govern in vivo response?. Biochemical Pharmacology. 78(7). 919–919. 1 indexed citations
2.
Rollema, Hans, Jotham W. Coe, Leslie K. Chambers, et al.. (2007). Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation. Trends in Pharmacological Sciences. 28(7). 316–325. 185 indexed citations
3.
Rollema, Hans, Leslie K. Chambers, J.W. Coe, et al.. (2006). Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology. 52(3). 985–994. 446 indexed citations
4.
Siuciak, Judith A., Douglas S. Chapin, John F. Harms, et al.. (2006). Inhibition of the striatum-enriched phosphodiesterase PDE10A: A novel approach to the treatment of psychosis. Neuropharmacology. 51(2). 386–396. 226 indexed citations
5.
Chapin, Douglas S., Sheryl A. McCarthy, John F. Harms, et al.. (2003). The neurochemical and behavioral effects of papaverine in vivo suggest PDE10 inhibition is “antipsychotic”. Schizophrenia Research. 60(1). 114–114. 4 indexed citations
6.
Mansbach, Robert S., et al.. (2000). Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine. Psychopharmacology. 148(3). 234–242. 45 indexed citations
7.
Steece‐Collier, Kathy, Leslie K. Chambers, Sarah Jaw‐Tsai, Frank S. Menniti, & J. Timothy Greenamyre. (2000). Antiparkinsonian Actions of CP-101,606, an Antagonist of NR2B Subunit-Containing N-Methyl-d-Aspartate Receptors. Experimental Neurology. 163(1). 239–243. 110 indexed citations
8.
CHENARD, B. L., J. Bordner, Todd W. Butler, et al.. (1995). (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D-Aspartate Responses. Journal of Medicinal Chemistry. 38(16). 3138–3145. 150 indexed citations
9.
10.
Chambers, Leslie K. & Carol Van Hartesveldt. (1984). Effects of intrastriatal and intracortical scopolamine on behavior in rats. Pharmacology Biochemistry and Behavior. 21(3). 471–473. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. David Tingley Breakdown of academic impact, for papers by Salvador Sierra Breakdown of academic impact, for papers by Steven B. Sands Breakdown of academic impact, for papers by Martin R. Gluck Breakdown of academic impact, for papers by Srihari R. Tella Breakdown of academic impact, for papers by Richard E. Chipkin Breakdown of academic impact, for papers by Cornelia Dorner‐Ciossek Breakdown of academic impact, for papers by Elin Löf Breakdown of academic impact, for papers by L. Oreland Breakdown of academic impact, for papers by Gunnar Flik
Rankless by CCL
2026